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Abstract 
 
Latent fingerprints provide a potential route to the secure, high throughput and non-invasive 
detection of drugs of abuse.  In this study we show for the first time that the excreted metabolites of 
drugs of abuse can be detected in fingerprints using ambient mass spectrometry.  Fingerprints and 
oral fluid were taken from patients attending a drug and alcohol treatment service.  Gas 
chromatography mass spectrometry (GC-MS) was used to test the oral fluid of patients for the 
presence of cocaine and benzoylecgonine.  The corresponding fingerprints were analysed using 
Desorption Electrospray Ionization (DESI) which operates under ambient conditions and Ion 
Mobility Tandem Mass Spectrometry Matrix Assisted Laser Desorption Ionization (MALDI-IMS-
MS/MS) and Secondary Ion Mass Spectrometry (SIMS).  The detection of cocaine, 
benzoylecgonine (BZE) and methylecgonine (EME) in latent fingerprints using both DESI and 
MALDI showed good correlation with oral fluid testing.  The sensitivity of SIMS was found to be 
insufficient for this application.  These results provide exciting opportunities for the use of 
fingerprints as a new sampling medium for secure, non-invasive drug detection.  The mass 
spectrometry techniques used here offer a high level of selectivity and consume only a small area of 
a single fingerprint, allowing repeat and high throughput analyses of a single sample.   
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Introduction 
The drug testing industry is worth several billion dollars worldwide, and is routinely used by 
probation services, prisons, courts and other law enforcement agencies.  Recently there has been a 
push towards workplace drug testing as well as new initiatives to test motorists for drug driving [1].  
Drug testing is usually carried out by taking a sample of blood or urine from a suspect and using 
either an antibody assay or chromatographic analysis to detect the relevant drug and its metabolites.  
However, these methods of sampling have limitations – blood testing can require trained staff, urine 
testing has associated privacy concerns and in both cases the samples must be treated as a biological 
hazard, which increases the complexity of sample handling in terms of storage and disposal.  Oral 
fluid and sweat have been proposed as alternative non-invasive collection matrices. These matrices, 
as well as oral fluid and sweat, frequently require extraction steps from the collection devices or 
precipitation from the biological fluids prior to analysis and this contributes to the cost of analysis  
[2]. 
In contrast, a latent fingerprint can be deposited quickly and transported easily. The identity of the 
donor is encapsulated within the fingerprint ridge detail, making the test impossible to falsify.  It 
has recently been shown that drugs and their metabolites can be detected in latent fingerprints using 
antibody reagents [3].  Whilst antibody reagents provide a rapid screening test, non-specific binding 
can lead to false positive results.  Mass spectrometry techniques provide a higher level of 
specificity, providing confirmation of the identity of the substance detected.   
Recent work by Goucher et al [4] has shown that liquid chromatography mass spectrometry (LC-
MS) can be used to detect lorazepam, methadone and their metabolites in latent fingerprints.  
However, a positive detection was only achieved when ten fingerprints were used (and consumed) 
in combination, making it impractical for use in the field as this precludes repeat analysis.  In 
contrast, recent developments in surface mass spectrometry allow in-situ analyses of a small area 
(less than 100 x 100 µm) of a sample under atmospheric pressure conditions.  This provides the 
potential for rapid sample throughput (often a few seconds per sample, compared with several hours 
for LC-MS when sample preparation is taken into account), a demonstration that the substance of 
abuse resides in the fingerprint and not the substrate and the opportunity to take repeat tests. These 
techniques have been applied previously to fingerprints that have been deliberately contaminated by 
drugs via contact [5-7] but (to our knowledge) not to unambiguously confirm the presence of drug 
metabolites in the fingerprints of drug users.   In order to confirm ingestion of a drug (as opposed to 
contact), detection of drug metabolites is essential.  Rowell et al [8] used surface assisted laser 
desorption ionization (SALDI) under vacuum conditions to detect the major metabolite of 
methadone in natural fingerprints, and was unable to confirm its presence using tandem mass 
spectrometry. 
Of the many surface mass spectrometry techniques available, matrix assisted laser desorption 
ionization (MALDI) [9-11], desorption electrospray ionization (DESI) [5] and secondary ion mass 
spectrometry (SIMS) [12-14] have been previously shown to provide chemical images of 
endogenous and exogenous compounds in a latent fingerprint. In this context, the techniques offer 
complementary features, these being high sensitivity (MALDI), quantitative precision (SIMS) and 
high throughput (DESI).  All three of the techniques can operate under atmospheric pressure 
conditions, allowing high throughput analysis.  In this paper, we will show for the first time that 
  
cocaine and its metabolites benzoylecgonine (BZE) and methylecgonine (EME) can be detected by 
these surface mass spectrometry techniques in latent fingerprints, and in particular under 
atmospheric pressure conditions, offering an exciting new opportunity for drug testing.   
 
Materials and Methods 
Cocaine, EME, acetone and acetonitrile (ACN) were obtained from Sigma Aldrich (St. Louis, 
USA). BZE was obtained either from Sigma Aldrich (St. Louis, USA) or from Sigma Aldrich 
(Poole, UK). Methanol was obtained either from Rathburn (Walkerburn, UK) or from Sigma 
Aldrich (Poole, UK). Trifluoroacetic acid (TFA), and α-cyano-4-hydroxycinnamic acid (α-CHCA) 
were purchased from Sigma Aldrich (Poole, UK). Double-side conductive carbon tape was obtained 
from TAAB (Aldermaston, UK).  
Sample preparation  
Latent Fingerprints 
Latent fingerprints were obtained from five individuals who were attending a drug and alcohol 
treatment service to receive treatment for drug dependence.  "Natural" fingerprints were deposited 
onto clean glass slides at a pressure between 400-1000 g and barcoded, before being shipped to the 
two analyzing laboratories. The fingerprints were then stored in a freezer at each lab at -80oC.  A 
corresponding oral fluid sample was collected from each patient using a Quantisaltm collection kit, 
Alere Toxicology, UK.  The oral fluid samples were screened for cocaine and benzoylecgonine 
BZE using a standard drug screening procedure utilizing GC-MS/MS at LGC Forensics, 
Teddington, Middlesex.  A favourable ethical opinion for sample collection and analysis was 
granted from the National Research Ethics Service.  In line with the ethics protocol, the patients 
were not asked whether they had used drugs. 
MALDI 
 
For MALDI analyses, the fingerprints were taken out of storage and a 0.5 µL BZE standard solution 
at a concentration of 100 µg/mL in 1:9 methanol: water mixed 1:1 with a solution of 5 mg/mL α-
CHCA in 70:30 ACN: 0.5% TFA was then spotted onto an area of the glass slide away from the 
mark. Both the fingerprint and the standard on the glass slide were allowed to dry in a vacuum 
desiccator for 20 minutes prior to analysis. The entire fingermark was spotted at random points with 
the MALDI matrix before spectral acquisition.  Fingerprints were analysed approximately 3 months 
after deposition. 
DESI and SIMS 
Gels containing standards of cocaine, BZE and EME at concentrations of 5, 50, 500 and 5000 ng/ml 
were pipetted onto glass slides and smeared across the slides to create a uniform layer.  The gels, 
which were a few mm in thickness, were made of synthetic gelatine (Sigma Aldrich, UK) and 
analysed using DESI and SIMS.  No sample preparation was required for the fingerprint samples.  
Fingerprints were analysed approximately 1 month after deposition. 
Instrumentation 
MALDI ion mobility tandem mass spectrometry (MALDI-IMS-MS/MS) analysis was conducted 
using a SynaptTM G2 HDMS mass spectrometer (Waters Corporations, Manchester, UK) 
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incorporating a Nd:YAG laser operating at 1 kHz.  Spectra were acquired in positive and resolution 
(‘Res’) mode in the mass range between m/z 100-1000 with a laser power of 200 (a.u.). Transfer 
fragmentation was used, allowing for ions to be separated based on their mobility and then 
subjected to collision induced dissociation in the Transfer T-Wave™. This maintained that product 
ions retained the same ion drift time as their corresponding precursor ion. Collision energy was 
applied at 26 eV for the dissociation of BZE. Prior to analysis, calibration was performed in the 
specified mass range using Glu-1-fibrinopeptide. Data processing of all spectra was performed 
using MassLynx 4.1 (Waters Corporation, Manchester, UK).   
DESI analyses were carried out at the National Physical Laboratory, Teddington using a DESI 2D 
Omni Spray Ion Source (Prosolia, Indianapolis, IN, USA) and an LTQ Orbitrap Velos mass 
spectrometer (Thermo Scientific, Bremen, Germany), optimised as outlined in Reference 15. Data 
were acquired using the Orbitrap mass analyser with the highest resolution setting of 100,000 (at 
m/z 400), except where stated when the linear ion trap analyser was used.  The solvent composition 
was 90:10 MeOH:H2O supplied at a flow rate of 1.5 µL/min using a 5 kV bias.  The spray was 
directed through a 50 micron capillary, giving a spot of approximately 300 x 300 µm on the sample 
[16].  Approximately 1 mm2 of sample was consumed during the analysis. Spectra were collected in 
positive ion mode using both full scan mode and MS/MS mode.  
SIMS analyses were carried out using an ION-TOF GmbH (Münster, Germany) TOF SIMS 5 
instrument at the University of Surrey, UK.  A 25 keV Bi3+ primary ion beam delivering 0.18 pA of 
current was employed.  Images were acquired at 128 × 128 resolution in the MacroRaster mode of 
operation.  Scans of 500 x 500 µm were acquired.  Image data were acquired using 512 cycles per 
pixel point with 1 scan per pixel. A cycle time of 100 µs was employed.  Mass calibration was 
performed by assigning peaks with a known mass using IonSpec software (version 4.1). Calibration 
was carried out using the following ions: CH3, Na, C2H3, CHO, C2H5, C3H5, C2H3O, C3H7, C2H5O, 
C4H5, C3H3O, C4H7, C3H5O, C4H9, C6H5, C7H7, and Si2C5H15O. 
 
Results 
MALDI IMS-MS/MS 
The ion mobility function can provide superior separation of isobaric ions and sensitivity, as ions 
are separated, in addition to their m/z, also on the basis of a specific ‘drift time’ (DT) that is unique 
to that particular ion as it is linked to their collisional cross section[17]. This allows for the reliable 
detection of biologically relevant concentrations. In this instance, MALDI-IMS-MS/MS has been 
employed to confirm the presence of BZE based on the matching of the product ions and their DT’s 
in the fingerprint and in the BZE standard. MALDI IMS-MS/MS analysis of both the standard and 
the mark allowed for Drift Scope Plots (a graphical representation of the ion mobility separation) to 
be generated and select DT regions of interest containing both the parent and the corresponding 
product ions (Figure 1A). Spectra from these acquisitions were interrogated for a product ion 
derived from the collision induced dissociation of BZE which directly corresponded to those 
observed in the standard (m/z 168.1033) (Figure 1B). Drift time chromatograms could then be 
produced based on the DT of this product ion, showing that the BZE product ion in the standard and 
the mark directly coincided (Figure 1C).  These data prove, unequivocally, that it is possible to 
  
detect excreted BZE contained within the fingerprint residue with corresponding oral fluid above 
the  16 ng/ml cut-off determined by the service provider’s GC-MS protocol [18] (although it is 
unknown at the present what is the lowest limit of detection and limit of quantification for 
fingerprint residue) and highlight the selectivity and sensitivity of modern analytical techniques 
such as ion mobility mass spectrometry. 
 
DESI 
Analysis of the standards showed that detectable signals for cocaine and BZE were present above 5 
ng/ml, and above 50 ng/ml for EME.  In Figure 2, spectra are presented which show positive 
identification of cocaine, BZE and EME in a fingerprint sample.  Figure 2A shows the MS/MS 
spectrum from a fingerprint for ions with m/z 304, with the (M+H)+ peak for cocaine detected at a 
mass accuracy of 4.8 ppm (in full scan mode this was improved to 0.807 ppm) and the detection of 
the fragment ion at m/z 182. Similarly, Figure 2B shows the MS/MS spectrum from a fingerprint for 
ions with m/z 290, with the (M+H)+ peak for BZE detected at a mass accuracy of 5.0 ppm 
(0.016ppm in full scan mode), and detection of the fragment ion at m/z 168, confirming the 
presence of BZE in the fingerprint. No signal was detected when the spray was moved away from 
the fingerprint.   Finally, Figure 2C shows the MS/MS spectrum, using the linear ion trap analyser, 
from a fingerprint for ions with m/z 200, with the (M+H)+ peak for EME and detection of the 
fragment ion at m/z 182, confirming the presence of EME in the fingerprint. Using the Orbitrap 
mass analyser in full scan mode, EME was detected with a mass accuracy of 0.200 ppm.  Table 1 
compares the results of oral fluid testing and fingerprint testing from DESI of four donors’ 
fingerprints.  Donors 1a and 1b represent different fingerprints from the same donor, and there is 
direct correspondence between the oral fluid test and the two fingerprints analysed by DESI. A 
similar result is seen for Donor 3.  Donor 2’s oral fluid tested negative, and the absence of a 
detectable signal in the DESI spectra from Donor 2’s fingerprints are in direct agreement with this.  
The oral fluid test for Donor 4 tested positive for cocaine and this is also detected in Donor 4’s 
fingerprint.  However, EME and BZE were not detected in the fingerprints from this donor. 
Table 2 presents data relating to the qualitative repeatability of the DESI method.  Three 
fingerprints were taken from each of a further two donors who tested positive for cocaine in their 
oral fluid. Three separate points were analysed on each fingerprint.  Table 2 shows that cocaine and 
EME were detected at every point analysed.  BZE was detected in 17 out of 18 of the analysis 
points. 
 
SIMS 
SIMS analysis of the standards revealed peaks at m/z 168, 124, 105 and 82, representing fragments 
of cocaine, BZE and EME.  Molecular ion peaks could be seen only with the highest concentration 
of the analytes.  In the latent fingerprint samples, only the peak at m/z 82 was detected.  
 
Discussion 
MALDI IMS-MS/MS and DESI analysis of a "natural" latent fingerprint allowed for the successful 
detection of the excreted primary metabolite, BZE.  DESI was also able to detect EME and, at the 
time of the MALDI analysis, researchers were specifically asked to look for BZE only, therefore no 
comparative conclusions can be made on the feasibility of MALDI to detect this secondary 
metabolite.  
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The ability to detect excreted substances in latent fingerprints proves that surface mass spectrometry 
techniques could provide the drug testing industry with an exciting new and complementary tool, 
potentially allowing differentiation between drug consumption and contact solely based on the 
presence of metabolites in the residue.  The significance of detecting cocaine metabolites in a 
fingerprint is currently unknown, because it is not known whether cocaine in fingerprint residue 
from contact could metabolise on the skin’s surface.  Furthermore, the possibility of absorption and 
metabolism of contact residues and the potential for secondary transfer has never been investigated. 
Although an image of the distribution of these excreted illicit substances in the fingerprint samples 
has not yet been attempted by either technique, the use of these techniques in profiling mode 
enables a rapid confirmatory screening for drugs of interest in less than 2 minutes.   
The correspondence between the DESI and MALDI results and the oral fluid measurements is 
promising, but also shows the importance of developing a quantitative test with a cut-off level.  The 
DESI result for Donor 4 shows that whilst this donor’s oral fluid was above the oral fluid screening 
test cut-off level, only cocaine (and not BZE or EME) was detected in the fingerprint.  This could 
be due to a difference in the (currently unknown) detection window for these metabolites in 
fingerprints compared with oral fluid or it may be a consequence of insufficient sensitivity of the 
DESI technique.   
No quantification of the DESI data was attempted at this stage since a matrix-matched standard 
does not exist.  Additionally, since the fingerprints are not spatially uniform, an appropriate 
sampling regime should be developed.  The difficulty with quantification of a substance within 
fingerprint residue is that there is currently no accepted method for determining how much material 
was deposited in the finger deposition.  In contrast, in blood, urine or oral fluid, the sample volume 
is known.  It has been shown previously using an LC-MS method to detect caffeine in fingerprints 
that different fingers gave different results, presumably due to different contact pressure and/or 
deposition area from different fingers [19].   We are currently investigating the validity of using 
different endogenous compounds within a fingerprint for normalisation purposes.   Further studies 
are necessary in this area to establish a quantitative procedure. 
Whilst SIMS has been previously shown to be a useful technique for imaging endogenous 
compounds in latent fingerprints [13,14], its suitability for the detection of drug metabolites in 
fingerprints is questionable, under the analytical conditions used here.  The high level of 
fragmentation results in only the detection of the fragment ion at m/z 82 in fingerprint samples and 
standards of concentrations below 5000 ng/ml.  This fragment is common to cocaine, BZE and 
EME as well as other compounds, and therefore the selectivity is insufficient for toxicological 
application.  It should be noted however, that Ar cluster SIMS sources can provide significantly 
higher molecular ion yields than Bi SIMS for organic compounds, and this may yield the desired 
selectivity in fingerprint samples.  If this were the case, SIMS may provide superior opportunities 
for quantification compared with DESI and MALDI. 
 
Conclusion 
We have demonstrated the use of established and emerging analytical techniques for the analysis of 
cocaine and its metabolites in natural fingerprints.  DESI was carried out under ambient conditions, 
and atmospheric pressure MALDI systems are also available.  This, combined with the ability to 
  
analyse the sample in-situ and with minimal sample preparation allows for very rapid sample 
throughput compared with chromatographic methods.  The high sensitivity of the methods and 
selectivity to the analytes described has enabled us to detect metabolites of cocaine drugs from 
those who use illicit substances.  Secondly, although the fingerprints are not spatially uniform, we 
are optimistic that these approaches can be developed for quantitative analysis of fingerprint 
residues. 
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  Oral fluid 
Screening Result 
DESI fingerprint analysis 
Donor   Cocaine BZE EME 
DESI  
    
1a Positive y y y 
1b Positive y y y 
2 Negative n n n 
3 Positive y y y 
4 Positive y n n 
MALDI 
    
5 Positive y y N/A 
 
Table 1 : Oral fluid test results and corresponding DESI and MALDI signals in the fingerprints of 
five donors 
 
  Position Cocaine BZE EME 
Donor 6 
Lthumb 1    
  2    
  3  ⌧  
Rindex 1    
  2    
  3    
Rring 1    
  2    
  3    
Donor 7 
Rindex 1    
  2    
  3    
Rmiddle 1    
  2    
  3    
Rthumb 1    
  2    
  3    
 
Table 2 : DESI signals for cocaine, BZE and EME across three positions on three different 
fingerprints of two donors  
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Figure 1 Detection of BZE from a fingerprint from a drug user in a rehabilitation centre by MALDI 
IMS-MS/MS. (Figure 1A) Drift scope plots of BZE standard and BZE in the fingerprint (generated 
through transfer fragmentation experiment). (Figure 1B) MS/MS spectra of BZE standard and BZE 
in the fingerprint after the selection of the BZE parent ion and products ion same drift time plume in 
the fingerprint and in the standard. Selection of the ion product at m/z 168.1033 in common to the 
BZE standard and BZE in fingerprint showing superimposable drift time chromatograms. 
 
 
 
 
 
  
 
 
Figure 2 Detection of cocaine, BZE and EME in a fingerprint from a drug user attending a 
rehabilitation centre using DESI MS/MS. Spectra from a fingerprint with ions of m/z (Figure 1A) 
304 (cocaine) (Figure 1B) 290 (BZE) (Figure 1C) 200 (EME) 
 
 
